These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2820772)

  • 21. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ; Zhou HL; Burman M; Huang LB
    Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional identification of phosphodiesterase activity in human trabecular meshwork cells.
    Zhou L; Thompson WJ; Potter DE
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):317-22. PubMed ID: 10977127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ca(2+)/calmodulin-dependent cyclic nucleotide phosphodiesterase in cGMP metabolism in rabbit parotid acinar cells.
    Sairenji N; Satoh K; Sugiya H
    Biomed Res; 2006 Feb; 27(1):37-44. PubMed ID: 16543664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic 3',5'-adenosine monophosphate phosphodiesterase (cAMP PDE) and cyclic 3',5'-guanosine monophosphate phosphodiesterase (cGMP PDE) in microvessels isolated from bovine cortex.
    Stefanovich V
    Neurochem Res; 1979 Dec; 4(6):681-7. PubMed ID: 232543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic nucleotide content and phosphodiesterase activity in the rds mouse (020/A) retina.
    Sanyal S; Fletcher R; Liu YP; Aguirre G; Chader G
    Exp Eye Res; 1984 Mar; 38(3):247-56. PubMed ID: 6327341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.
    Zhang KY; Card GL; Suzuki Y; Artis DR; Fong D; Gillette S; Hsieh D; Neiman J; West BL; Zhang C; Milburn MV; Kim SH; Schlessinger J; Bollag G
    Mol Cell; 2004 Jul; 15(2):279-86. PubMed ID: 15260978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
    Lugnier C; Gauthier C; Le Bec A; Soustre H
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The identification and characterization of two cyclic nucleotide phosphodiesterases from bovine adrenal medulla.
    Sabatine JM; Coffee CJ
    Arch Biochem Biophys; 1986 Aug; 249(1):95-105. PubMed ID: 3017224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN; Bobruskin ID; Severin SE
    Biokhimiia; 1995 May; 60(5):694-708. PubMed ID: 7662796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of cyclic nucleotide phosphodiesterases in ischemic preconditioning.
    Lochner A; Genade S; Tromp E; Opie L; Moolman J; Thomas S; Podzuweit T
    Mol Cell Biochem; 1998 Sep; 186(1-2):169-75. PubMed ID: 9774198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of phosphodiesterase and protein kinase G on nitric oxide-induced inhibition of prolactin release from the rat anterior pituitary.
    Velardez MO; De Laurentiis A; del Carmen Díaz M; Lasaga M; Pisera D; Seilicovich A; Duvilanski BH
    Eur J Endocrinol; 2000 Aug; 143(2):279-84. PubMed ID: 10913949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue.
    Price B; Pyne NJ; Houslay MD
    Biochem Pharmacol; 1987 Dec; 36(23):4047-54. PubMed ID: 2825712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic 3',5'-nucleotide phosphodiesterase activities in the thyroid glands of patients with various disorders.
    Nagasaka A; Hidaka H
    J Clin Endocrinol Metab; 1980 Apr; 50(4):726-33. PubMed ID: 6245100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective alteration of Ca2+-dependent and Ca2+-independent cyclic nucleotide phosphodiesterase activity in rat cerebral cortex by cyclic nucleotides and their analogs.
    Davis CW
    Biochim Biophys Acta; 1982 Jul; 705(1):1-7. PubMed ID: 6288105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calmodulin-stimulated cyclic nucleotide phosphodiesterases in plasma membranes of bovine epididymal spermatozoa.
    Chaudhry PS; Casillas ER
    Arch Biochem Biophys; 1988 May; 262(2):439-44. PubMed ID: 2835007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
    Beatty CH; Herrington PT; Bocek RM
    Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic nucleotide phosphodiesterases in glomeruli of rat renal cortex.
    Torres VE; Hui YS; Shah SV; Northrup TE; Dousa TP
    Kidney Int; 1978 Nov; 14(5):444-51. PubMed ID: 220459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
    Sobolev AS; Rybalkin SD
    Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system.
    Maurice DH
    Front Biosci; 2005 May; 10():1221-8. PubMed ID: 15769620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.